R. Joel Welch
- Ophthalmology top 2%
- Ocular Oncology and Treatments 17
- Retinal Diseases and Treatments 5
- Glaucoma and retinal disorders 4
- Retinal and Optic Conditions 4
- Clinical Biochemistry top 5%
-
- Cancer Treatment and Pharmacology 3
-
- Retinal Development and Disorders 3
-
- Brain Metastases and Treatment 6
-
- Retinal and Macular Surgery 6
- Co-authors
- Yutaka YatomiCarol L. ShieldsFuqiang RuanJerry A. ShieldsMichael D. YuLauren A. DalvinYasuyuki IgarashiBasil K. Williams
- Journals
- Journal of Clinical Oncology (2 papers)Analytical Biochemistry (1 paper)FEBS Letters (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
R. Joel Welch
34 papers receiving 714 citations
Peers
Comparison fields: 5 of 79
- Ophthalmology 354
- Clinical Biochemistry 82
- Oncology 152
- Molecular Biology 342
- Cell Biology 76
Countries citing papers authored by R. Joel Welch
This map shows the geographic impact of R. Joel Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Joel Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Joel Welch more than expected).
Fields of papers citing papers by R. Joel Welch
This network shows the impact of papers produced by R. Joel Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Joel Welch. The network helps show where R. Joel Welch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Joel Welch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 15 | |
| 2 | 2019 | 0 | |
| 3 | Management of Retinoblastoma in Older Children (>5 years) Using Intra-Arterial Chemotherapy: Comparison of Outcomes to Pre-Chemotherapy and Intravenous Chemotherapy Eras | 2019 | 2 |
| 4 | 2019 | 7 | |
| 5 | 2019 | 22 | |
| 6 | 2019 | 87 | |
| 7 | 2019 | 10 | |
| 8 | 2019 | 7 | |
| 9 | 2018 | 9 | |
| 10 | 2018 | 12 | |
| 11 | 2018 | 9 | |
| 12 | 2018 | 2 | |
| 13 | 2018 | 37 | |
| 14 | Multimodal imaging characteristics of solitary idiopathic choroiditis in 26 cases | 2017 | 1 |
| 15 | 2017 | 4 | |
| 16 | 2017 | 6 | |
| 17 | 2005 | 35 | |
| 18 | The Martin County Project: A Student, Faculty, and Citizen Effort at Researching the Effects of a Technological Disaster | 2002 | 2 |
| 19 | 1997 | 45 | |
| 20 | 1995 | 37 |
About R. Joel Welch
R. Joel Welch is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Clinical Biochemistry, having authored 40 papers that have together received 729 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (17 papers), Brain Metastases and Treatment (6 papers), Retinal and Macular Surgery (6 papers), Retinal Diseases and Treatments (5 papers), Glaucoma and retinal disorders (4 papers), Retinal and Optic Conditions (4 papers), Cancer Treatment and Pharmacology (3 papers) and Retinal Development and Disorders (3 papers). The work is most often cited by research in Ophthalmology (354 citations), Clinical Biochemistry (82 citations) and Oncology (152 citations). R. Joel Welch has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Yutaka Yatomi, Carol L. Shields, Fuqiang Ruan, Jerry A. Shields, Michael D. Yu, Lauren A. Dalvin, Yasuyuki Igarashi, Basil K. Williams, David Ancona‐Lezama and Douglass M. Turnbull. Their work appears in journals such as Journal of Clinical Oncology, Analytical Biochemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.